Cap-assisted Endoscopic Sclerotherapy for Internal Hemorrhoids and Rectal Prolapse

Launched by THE SECOND HOSPITAL OF NANJING MEDICAL UNIVERSITY · Apr 12, 2019

Keywords

ClinConnect Summary

This clinical trial is studying a treatment called Cap-assisted Endoscopic Sclerotherapy (CAES) for people with internal hemorrhoids and rectal prolapse. The goal is to see how well two different types of needles (long and short) work in helping to treat these conditions. The trial is currently looking for participants of all ages who have been diagnosed with internal hemorrhoids and rectal prolapse, with or without external hemorrhoids. Patients will need to be prepared for bowel examination before the procedure.

To join the trial, participants must not have a history of certain complications, such as severe hemorrhoids or specific bowel disorders, and should not be dealing with acute issues like uncontrolled high blood pressure. Those who are pregnant or have serious health conditions may also be excluded. If eligible, participants can expect to undergo a treatment that aims to relieve their symptoms, and they will be monitored for safety and effectiveness throughout the trial. This study offers a chance to explore new treatment options for common but often uncomfortable conditions.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Patients with internal hemorrhoids and rectal prolapse, combined with external hemorrhoids or without external hemorrhoids.
• • 2. Patients with bowel preparation.
• Exclusion Criteria:
• • 1. History of anoscopic/endoscopic sclerotherapy.
• • 2. Patients with acute thrombotic external hemorrhoids.
• • 3. Patients with serious internal hemorrhoids of grade IV.
• • 4. Patients with anal stenosis, anal fissure, fistula, fecal incontinence, ulcerative colitis, Crohn's disease.
• • 5. Patients with acute diarrhea in the past 24 hours.
• • 6. Hypertensive patients with uncontrolled blood pressure, patients with cerebrovascular accident and obvious bleeding tendency, pregnant women, mental disorders and decompensated cirrhosis.